Tissue Ki67 proliferative index expression and pathological changes in hemodialysis arteriovenous fistulae: Preliminary single-center results

Abstract

Background:

Arteriovenous fistula (AVF) for hemodialysis integrates outward remodeling with vessel wall thickening in response to drastic hemodynamic changes. Aim of this study is to determine the role of Ki67, a well-established proliferative marker, related to AVF, and its relationship with time-dependent histological morphologic changes.

Materials and methods:

All patients were enrolled in 1 year and stratified in two groups: (A) pre-dialysis patients submitted to first AVF and (B) patients submitted to revision of AVF. Morphological changes: neo-angiogenesis (NAG), myointimal thickening (MIT), inflammatory infiltrate (IT), and aneurysmatic fistula degeneration (AD). The time of AVF creation was recorded. A biopsy of native vein in Group A and of arterialized vein in Group B was submitted to histological and immunohistochemical (IHC) analysis. IHC for Ki67 was automatically performed in all specimens. Ki67 immunoreactivity was assessed as the mean number of positive cells on several high-power fields, counted in the hot spots.

Results:

A total of 138 patients were enrolled, 69 (50.0%) Group A and 69 (50.0%) Group B. No NAG or MIT were found in Group A. Seven (10.1%) Group A veins showed a mild MIT. Analyzing the Group B, a moderate-to-severe MIT was present in 35 (50.7%), IT in 19 (27.5%), NAG in 37 (53.6%); AD was present in 10 (14.5%). All AVF of Group B with the exception of one (1.4%) showed a positivity for Ki67, with a mean of 12.31 ± 13.79 positive cells/hot spot (range 0–65). Ki67-immunoreactive cells had a subendothelial localization in 23 (33.3%) cases, a myointimal localization in SMC in 35 (50.7%) cases. The number of positive cells was significantly correlated with subendothelial localization of Ki67 (p = 0.001) and with NA (p = 0.001).

Conclusions:

Native veins do not contain cycling cells. In contrast, vascular cell proliferation starts immediately after AVF creation and persists independently of the time the fistula is set up. The amount of proliferating cells is significantly associated with MIT and subendothelial localization of Ki67-immunoreactive cells, thus suggesting a role of Ki-67 index in predicting AVF failure.

Keywords

Arteriovenous fistula myointimal thickening Ki67 index pathological changes hemodialysis

Get full access to this article

View all access options for this article.

References

Lok

Huber

Lee

, et al. NKF.KDOQI clinical practice guidelines for vascular access: 2019 update. Am J Kidney Dis 2020; 75(4): S1–164.

Remuzzi

Bozzetto

Biological and physical factors involved in the maturation of arteriovenous fistula for hemodialysis. Cardiovasc Eng Technol 2017; 8(3): 273–279.

Tordoir

JHM

Zonnebeld

van Loon

, et al. Surgical and endovascular intervention for dialysis access maturation failure during and after arteriovenous fistula surgery: review of the evidence. Eur J Vasc Endovasc Surg 2018; 55(2): 240–248.

Wongmahisorn

Maturation of arteriovenous fistulas in patients with and without pre-existing hemodialysis catheters. Ann Med Surg 2019; 48: 11–16.

Paszkowiak

Dardik

Arterial wall shear stress: observations from the bench to the bedside. Vasc Endovascular Surg 2003; 37(1): 47–57.

Roy-Chaudhury

Spergel

Besarab

, et al. Biology of arteriovenous fistula failure. J Nephrol 2007; 20(2): 150–163.

Zonnebeld

Huberts

van Loon

, et al. Natural vascular remodelling after arteriovenous fistula creation in dialysis patients with and without previous ipsilateral vascular access. Eur J Vasc Endovasc Surg 2020; 59(2): 277–287.

Sobecki

Mrouj

Camasses

, et al. The cell proliferation antigen Ki-67 organises heterochromatin. eLife 2016; 5: e13722.

Sun

Kaufman

PD.

Ki-67: more than a proliferation marker. Chromosoma 2018; 127(2): 175–186.

10.

Mauro

Pini

Bianchini Massoni

, et al. A comparison of two surgical techniques for the second stage of brachiobasilic arteriovenous fistula creation. Artif Organs 2017; 41(6): 539–544.

11.

Schmidli

Widmer

Basile

, et al. Editor’s choice – vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2018; 55(6): 757–818.

12.

Brahmbhatt

Misra

The biology of hemodialysis vascular access failure. Semin Interv Radiol 2016; 33(1): 15–20.

13.

Bozzetto

Ene-Iordache

Remuzzi

Transitional flow in the venous side of patient-specific arteriovenous fistulae for hemodialysis. Ann Biomed Eng 2016; 44(8): 2388–2401.

14.

Alpers

Imrey

Hudkins

, et al.Histopathology of veins obtained at hemodialysis arteriovenous fistula creation surgery. J Am Soc Nephrol 2017; 28(10): 3076–3088.

15.

Cheung

Imrey

Alpers

, et al. Intimal Hyperplasia, stenosis, and arteriovenous fistula maturation failure in the hemodialysis fistula maturation study. J Am Soc Nephrol 2017; 28(10): 3005–3013.

16.

Cianciolo

Capelli

Cappuccilli

, et al. Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients. Clin Kidney J 2016; 9(2): 280–286.

17.

Chen

Schwartz

Simons

Endothelial-to-mesenchymal transition, vascular inflammation, and atherosclerosis. Front Cardiovasc Med 2020; 7(7): 53.

18.

Aitken

Jackson

Kong

, et al. Renal function, uraemia and early arteriovenous fistula failure. BMC Nephrol 2014; 15(1): 179.

19.

Nath

O’Brien

Croatt

, et al. The murine dialysis fistula model exhibits a senescence phenotype: pathobiological mechanisms and therapeutic potential. Am J Physiol Renal Physiol 2018; 315(5): F1493–F1499.

20.

Roy-Chaudhury

Sukhatme

Cheung

AK.

Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 2006; 17(4): 1112–1127.

21.

Wasse

Huang

Naqvi

, et al. Inflammation, oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients. J Vasc Access 2012; 13(2): 168–174.

22.

Roy-Chaudhury

Wang

Krishnamoorthy

, et al. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transplant 2009; 24(9): 2786–2791.

23.

Roy-Chaudhury

Lee

TC.

Vascular stenosis: biology and interventions. Curr Opin Nephrol Hypertens 2007; 16(6): 516–522.

24.

Roy-Chaudhury

Arend

Zhang

, et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis 2007; 50(5): 782–790.

25.

Stracke

Konner

Köstlin

, et al. Increased expression of TGF-β1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int 2002; 61(3): 1011–1019.

26.

Simone

Loverre

Cariello

, et al. Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis. J Nephrol 2014; 27(5): 555–562.

27.

Gallieni

Hollenbeck

Inston

, et al. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults. Nephrol Dial Transplant 2019; 34(3): ii1–ii42.